These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 12460096)
21. Infection and atherosclerosis--focus on cytomegalovirus and Chlamydia pneumoniae. Cheng JW; Rivera NG Ann Pharmacother; 1998 Dec; 32(12):1310-6. PubMed ID: 9876813 [TBL] [Abstract][Full Text] [Related]
22. Antibiotics effects in a rabbit model of Chlamydia pneumoniae-induced atherosclerosis. Fong IW J Infect Dis; 2000 Jun; 181 Suppl 3():S514-8. PubMed ID: 10839750 [TBL] [Abstract][Full Text] [Related]
27. Upregulation of extracellular matrix metalloproteinase inducer (EMMPRIN) and gelatinases in human atherosclerosis infected with Chlamydia pneumoniae: the potential role of Chlamydia pneumoniae infection in the progression of atherosclerosis. Choi EY; Kim D; Hong BK; Kwon HM; Song YG; Byun KH; Park HY; Whang KC; Kim HS Exp Mol Med; 2002 Dec; 34(6):391-400. PubMed ID: 12526080 [TBL] [Abstract][Full Text] [Related]
28. Review of evidence for a connection between Chlamydia pneumoniae and atherosclerotic disease. Dugan JP; Feuge RR; Burgess DS Clin Ther; 2002 May; 24(5):719-35. PubMed ID: 12075941 [TBL] [Abstract][Full Text] [Related]
29. Chlamydia pneumoniae and coronary heart disease. Carlisle SS; Nahata MC Ann Pharmacother; 1999 May; 33(5):615-22. PubMed ID: 10369627 [TBL] [Abstract][Full Text] [Related]
30. [Infections with Chlamydia pneumoniae, Helicobacter pylori or cytomegalovirus and atherosclerosis]. Grabczewska Z; Nartowicz E Przegl Lek; 1999; 56(9):584-7. PubMed ID: 10695364 [TBL] [Abstract][Full Text] [Related]
31. Serologic and histopathologic study of Chlamydia pneumoniae infection in atherosclerosis: a possible pathogenetic mechanism of atherosclerosis induced by Chlamydia pneumoniae. Song YG; Kwon HM; Kim JM; Hong BK; Kim DS; Huh AJ; Chang KH; Kim HY; Kang TS; Lee BK; Choi DH; Jang YS; Kim HS Yonsei Med J; 2000 Jun; 41(3):319-27. PubMed ID: 10957885 [TBL] [Abstract][Full Text] [Related]
32. Chlamydia pneumoniae, antimicrobial therapy and coronary heart disease: a critical overview. Gupta S; Camm AJ Coron Artery Dis; 1998; 9(6):339-43. PubMed ID: 9812184 [TBL] [Abstract][Full Text] [Related]
33. Chlamydia pneumoniae, strain TWAR and atherosclerosis. Grayston JT; Kuo CC; Campbell LA; Benditt EP Eur Heart J; 1993 Dec; 14 Suppl K():66-71. PubMed ID: 8131792 [TBL] [Abstract][Full Text] [Related]
34. Chlamydia pneumoniae and vascular disease: an update. Mussa FF; Chai H; Wang X; Yao Q; Lumsden AB; Chen C J Vasc Surg; 2006 Jun; 43(6):1301-7. PubMed ID: 16765261 [TBL] [Abstract][Full Text] [Related]
35. Is infection with Chlamydia pneumoniae a causative agent in atherosclerosis? Kuo C; Campbell LA Mol Med Today; 1998 Oct; 4(10):426-30. PubMed ID: 9793930 [TBL] [Abstract][Full Text] [Related]
36. Antibiotic therapy in coronary heart disease--where do we currently stand? Anand V; Gupta S Cardiovasc Drugs Ther; 2001; 15(3):209-10. PubMed ID: 11713887 [TBL] [Abstract][Full Text] [Related]
38. [Atherosclerosis and inflammation--role of chlamydia pneumoniae infection what do we know to date?]. Fudal M; Wilczewski P Wiad Lek; 2004; 57(3-4):151-5. PubMed ID: 15307523 [TBL] [Abstract][Full Text] [Related]
39. Chlamydia pneumoniae and cardiovascular disease: an evolutionary perspective on infectious causation and antibiotic treatment. Ewald PW; Cochran GM J Infect Dis; 2000 Jun; 181 Suppl 3():S394-401. PubMed ID: 10839723 [TBL] [Abstract][Full Text] [Related]
40. [Atherosclerosis--a chronic infectious disease caused by Chlamydia pneumoniae]. Stille W; Stephen C Versicherungsmedizin; 1999 Mar; 51(1):12-7. PubMed ID: 10200611 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]